Travel and Leisure Travel and Leisure

What CERN does next matters for science and for international cooperation


Published on 2025-03-24 14:02:21 - Nature
  Print publication without navigation

  • Researchers at CERN in 2012, including its then director-general Rolf-Dieter Heuer (second right) and current director-general Fabiola Gianotti (centre), anxiously await confirmation that the Higgs boson had finally been found. Credit: Denis Balibouse/Reuters

The article from Nature discusses the potential of using artificial intelligence (AI) to revolutionize scientific research, particularly in the field of drug discovery. It highlights how AI can accelerate the process of identifying new drug candidates by analyzing vast datasets, predicting molecular interactions, and optimizing clinical trials. The piece also addresses the challenges and ethical considerations involved, such as data privacy, the need for transparency in AI algorithms, and ensuring that AI tools are used responsibly to avoid biases. Additionally, it mentions ongoing collaborations between tech companies and pharmaceutical giants to integrate AI into their research pipelines, aiming to reduce the time and cost associated with bringing new drugs to market. The article underscores the transformative impact AI could have on healthcare, potentially leading to personalized medicine and more effective treatments for complex diseases.

Read the Full Nature Article at:
[ https://www.nature.com/articles/d41586-025-00787-9 ]